Midwest Institute for Clinical Research
Private Company
Funding information not available
Overview
Midwest Institute for Clinical Research (MICR) is a well-established, private contract research organization (CRO) with over 35 years of experience in the Indianapolis area. It operates as a service provider, conducting Phase I-IV clinical trials on behalf of pharmaceutical and medical device sponsors, having executed over 550 protocols. The company's business model centers on recruiting volunteer participants for paid clinical trials, providing a critical link between sponsors, patients, and regulatory outcomes. Its reputation is built on a commitment to quality, detail, and personalized care for trial volunteers.
Technology Platform
Integrated clinical trial operational infrastructure and volunteer recruitment ecosystem, including clinical facilities, patient screening systems, data management, and regulatory compliance expertise focused on efficient trial execution.
Opportunities
Risk Factors
Competitive Landscape
MICR competes in the fragmented clinical research site and mid-sized CRO market. Competitors range from large global CROs (IQVIA, Parexel, PPD) to other regional, site-focused research organizations and academic medical centers. Its differentiation lies in its long-standing local reputation, personalized volunteer care, and focused operational quality in the Indianapolis region.